Sudarshan Pharma Industries Limited (BOM:543828)
India flag India · Delayed Price · Currency is INR
35.60
-0.71 (-1.96%)
At close: Aug 17, 2026

BOM:543828 Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
-11.355.511.44117.192.36
Short-Term Investments
--1515--
Cash & Short-Term Investments
11.3511.3520.5116.44117.192.36
Cash Growth
-44.66%-44.66%24.76%-85.97%4865.47%-81.19%
Accounts Receivable
-2,3331,6021,225815.09734.77
Other Receivables
--9.4277.166.12.69
Receivables
-2,3331,6571,303929.89737.46
Inventory
-2,1871,405857.41745.68468.7
Prepaid Expenses
--20.3117.844.761.82
Other Current Assets
-370.5245.71177.89188.7185.46
Total Current Assets
-4,9033,3482,3721,9861,296
Property, Plant & Equipment
-808.48260.91224.1190.0368.84
Long-Term Investments
-0.02288.4123.41123.410.02
Goodwill
-52.234.8843.59--
Other Intangible Assets
-99.683.316.158.971.19
Other Long-Term Assets
-554.4777.3251.185.850.49
Total Assets
-6,4174,0242,8312,3251,375

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
-1,877918.33567.15918.89737.51
Accrued Expenses
-0.198.6644.2929.124.25
Short-Term Debt
--1,566905.59183.52235.92
Current Portion of Long-Term Debt
-2,55136.8537.8729.6320.6
Current Portion of Leases
-13.08----
Current Income Taxes Payable
-71.6351.7524.366.43.26
Other Current Liabilities
-48.0415.4925.6517.224.7
Total Current Liabilities
-4,5612,5971,6051,1851,026
Long-Term Debt
-283.69104.6104.91127.8849.4
Long-Term Leases
-2.59----
Pension & Post-Retirement Benefits
--1.340.70.50.31
Long-Term Deferred Tax Liabilities
-1.512.860.181.81.41
Other Long-Term Liabilities
-5.343.543.480.090.11
Total Liabilities
-4,8542,7091,7141,3151,077

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
-240.66240.66240.66240.6697.49
Additional Paid-In Capital
--578.08578.1578.179.66
Retained Earnings
--457.86298.31190.97120.61
Comprehensive Income & Other
-1,31038.21---
Total Common Equity
1,5511,5511,3151,1171,010297.75
Minority Interest
-12.210.01---
Shareholders' Equity
1,5631,5631,3151,1171,010297.75
Total Liabilities & Equity
-6,4174,0242,8312,3251,375

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
2,8502,8501,7071,048341.04305.92
Net Cash (Debt)
-2,839-2,839-1,687-1,032-223.85-303.56
Net Cash Growth
------
Net Cash Per Share
-11.79-11.82-6.98-4.32-0.93-2.11
Filing Date Shares Outstanding
254.57223.46240.66240.66240.66166.78
Total Common Shares Outstanding
254.57223.46240.66240.66240.66146.23
Working Capital
-341.46751.53767.29801.45269.55
Book Value Per Share
6.946.945.464.644.202.04
Tangible Book Value
1,3991,3991,2771,0671,001296.56
Tangible Book Value Per Share
6.266.265.304.444.162.03
Land
--104.73104.73104.733.21
Buildings
--15.315.314.7714.77
Machinery
--122.53116.6792.1462.9
Construction In Progress
--60.4118.80.125.36